Three researchers at Fred Hutchinson Cancer Research Center recently were awarded a total of $1.5 million from the Andy Hill Cancer Research Endowment, a public-private partnership that supports cancer research in Washington. Until recently, the fund was known as the Andy Hill Cancer Research Endowment (CARE) Fund.
The awardees, all recent recruits to Fred Hutch, each of whom received individual grants of $500,000, are:
- Dr. Geoffrey Hill, a renowned bone marrow transplantation physician-scientist whose research focuses on better understanding of a transplantation side effect called graft-vs.-host disease, or GVHD.
- Dr. Thomas Kensler, an expert in carcinogenesis and chemoprevention whose laboratory focuses on using chemoprevention to establish safe, economical, and effective means for reducing cancer risks related to unavoidable environmental exposures.
- Dr. Evan Newell, a leading immunologist whose research focuses on using new technologies for identifying specific, accurate biomarkers of human health and disease, including cancer.
